Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis.

Silvia Svegliati, Giusi Marrone, Antonio Pezone, Tatiana Spadoni, Antonella Grieco, Gianluca Moroncini, Domenico Grieco, Maria Vinciguerra, Savina Agnese, Astrid Jüngel, Oliver Distler, Anna Maria Musti, Armando Gabrielli, Enrico V Avvedimento

Journal: Science signaling 2015;7(341):ra84

PMID: 25185156

Abstract

Systemic sclerosis (SSc) is an autoimmune disease characterized by extensive visceral organ and skin fibrosis. SSc patients have increased production of autoreactive antibodies and Wnt signaling activity. We found that expression of the gene encoding Wnt inhibitor factor 1 (WIF-1) was decreased in fibroblasts from SSc patient biopsies. WIF-1 deficiency in SSc patient cells correlated with increased abundance of the Wnt effector β-catenin and the production of collagen. Knocking down WIF-1 in normal fibroblasts increased Wnt signaling and collagen production. WIF-1 loss and DNA damage were induced in normal fibroblasts by either SSc patient immunoglobulins or oxidative DNA-damaging agents, such as ultraviolet light, hydrogen peroxide, or bleomycin. The DNA damage checkpoint kinase ataxia telangiectasia mutated (ATM) mediated WIF-1 silencing through the phosphorylation of the transcription factor c-Jun, which in turn activated the expression of the gene encoding activating transcription factor 3 (ATF3). ATF3 and c-Jun were recruited together with histone deacetylase 3 (HDAC3) to the WIF-1 promoter and inhibited WIF-1 expression. Preventing the accumulation of reactive oxygen species or inhibiting the activation of ATM, c-Jun, or HDACs restored WIF-1 expression in cultured SSc patient cells. Trichostatin A, an HDAC inhibitor, prevented WIF-1 loss, β-catenin induction, and collagen accumulation in an experimental fibrosis model. Our findings suggest that oxidative DNA damage induced by SSc autoreactive antibodies enables Wnt activation that contributes to fibrosis.

Copyright © 2014, American Association for the Advancement of Science.

Address: Dipartimento di Scienze Cliniche e Molecolari, Clinica Medica, Università Politecnica delle Marche, 60126 Ancona, Italy.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di napoli Federico II, 80132 Naples, Italy.; Dipartimento di Scienze Cliniche e Molecolari, Clinica Medica, Università Politecnica delle Marche, 60126 Ancona, Italy. Dipartimento di Medicina Interna, Ospedali Riuniti, 60126 Ancona, Italy.; Cancer Research UK, Clare Hall, London EN6 3LD, UK.; Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, 8091 Zurich, Switzerland.; Dipartimento di Farmacia e Scienze della Salute e della Nutrizione, Università della Calabria, Arcavacata di Rende (CS) 87036, Italy.; Dipartimento di Scienze Cliniche e Molecolari, Clinica Medica, Università Politecnica delle Marche, 60126 Ancona, Italy. Dipartimento di Medicina Interna, Ospedali Riuniti, 60126 Ancona, Italy. [email protected] [email protected].; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di napoli Federico II, 80132 Naples, Italy. [email protected] [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.